AMGN

How Amgen's Earnings Track Record Shapes Expectations Around the August 4 Report

Amgen has beaten Wall Street's bottom-line estimate in 7 of its last 8 reported quarters, an 88% beat rate, with an average earnings surprise of 9.4%. That consistency would normally suggest a bullish post-report setup, yet the price action tells a more complicated story. Across the same eight quarters, the average 5-day drift following the report is 2.95% to the upside, but the stock has not followed through in the direction of every beat. In the four most recent reports, all four were beats, yet two produced negative next-day reactions. On April 30, 2026, Amgen reported $5.15 EPS against a $4.77 estimate—an 8% surprise—but the stock fell 4.75% the next session and 4.96% over the following five trading days. By contrast, the February 3, 2026 beat of $5.29 versus $4.73, an 11.8% surprise, drove an 8.15% one-day gain and a 7.7% five-day gain. The November 4, 2025 report delivered a 12.4% surprise on $5.64 versus $5.02 and produced a 7.81% next-day pop followed by a 14.07% five-day rally. The August 5, 2025 quarter was another headline beat—$6.02 versus $5.28, a 14% surprise—but the stock dropped 5.14% the next day and 5.03% over the next five sessions. The lesson from the data is that Amgen's beats have been frequent and large, but the market's reaction has been directionally mixed, especially over the immediate one-to-five day window.

Reading the Options Tape and Positioning Into the 2026-08-04 Close

The next scheduled report arrives August 4, 2026 after the close, with the published consensus EPS estimate at $5.62. The options market's job in the sessions ahead is to encode the market's real expectation for a move, not just the analyst consensus. With Amgen's realized one-day post-earnings moves ranging from -5.14% to +8.15% over its last four reports, the at-the-money straddle at a given implied volatility level has a wide realized benchmark to clear. A straddle buyer needs the stock to move by more than the combined premium paid, and the February 3, 2026 (+8.15%) and August 5, 2025 (-5.14%) outcomes show that even the largest moves were still within a range that can swallow premium quickly on a smaller reaction. Unidirectional flow before the event can also create a gamma environment where hedging activity magnifies a post-report move once the stock crosses key strike clusters. At a price of $380.25, with the 50-day EMA at $362.11 and RSI at 59.8, the setup is not at an extreme, so the repricing after the release can be sharper if the $5.62 estimate is beaten or missed by a margin outside the recent 8% to 14% surprise band.

What a Disciplined Trader Watches After the Report

The historical pattern points to three things a trader can watch. First, the opening print versus the after-hours reaction: compare the size of the beat or miss against the $5.62 consensus to the prior four quarters. Second, the thresholds set by the prior one-day moves—the +8.15% gain from February 3, 2026 and the -5.14% drop from August 5, 2025 define the recent distribution, so a move beyond those levels would be an outlier. Third, the technical context: the 50-day EMA at $362.11 sits below the $380.25 price, while the RSI at 59.8 shows the stock is not overbought. Because two of the last four beats produced 5-day drops of -4.96% and -5.03%, the post-report narrative—guidance, pipeline commentary, and margin trends—is a larger variable than the headline beat alone. The data says verification through price action is preferable to assuming a beat translates into a continued rally.

For a more complete picture of how institutional investors are positioned into the August 4, 2026 report, readers should examine the full institutional verdict, which aggregates analyst revisions, fund flow trends, and options positioning beyond the headline earnings metrics.